| Symbol |
Name |
Standardized Value |
|
IRF7
|
interferon regulatory factor 7
|
3.863
|
|
IFNA1
|
interferon, alpha 1
|
2.843
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
2.768
|
|
TLR7
|
toll-like receptor 7
|
2.711
|
|
IRF3
|
interferon regulatory factor 3
|
2.674
|
|
TLR9
|
toll-like receptor 9
|
2.631
|
|
TLR3
|
toll-like receptor 3
|
2.589
|
|
RIGI
|
RNA sensor RIG-I
|
2.571
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
2.536
|
|
MYD88
|
myeloid differentiation primary response 88
|
2.523
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
2.478
|
|
MX1
|
MX dynamin-like GTPase 1
|
2.414
|
|
ISG15
|
ISG15 ubiquitin-like modifier
|
2.401
|
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
2.393
|
|
IRF9
|
interferon regulatory factor 9
|
2.31
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
2.296
|
|
TBK1
|
TANK-binding kinase 1
|
2.294
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
2.288
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
2.277
|
|
MAVS
|
mitochondrial antiviral signaling protein
|
2.249
|
|
IFNG
|
interferon, gamma
|
2.237
|
|
IKBKE
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon
|
2.232
|
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa
|
2.219
|
|
IFIT1
|
interferon-induced protein with tetratricopeptide repeats 1
|
2.204
|
|
IRAK4
|
interleukin-1 receptor-associated kinase 4
|
2.193
|
|
STAT2
|
signal transducer and activator of transcription 2, 113kDa
|
2.191
|
|
IFNA2
|
interferon, alpha 2
|
2.177
|
|
TRAF3
|
TNF receptor-associated factor 3
|
2.171
|
|
IL6
|
interleukin 6
|
2.166
|
|
IRF1
|
interferon regulatory factor 1
|
2.15
|
|
IL1B
|
interleukin 1, beta
|
2.121
|
|
TLR8
|
toll-like receptor 8
|
2.113
|
|
RSAD2
|
radical S-adenosyl methionine domain containing 2
|
2.079
|
|
TLR4
|
toll-like receptor 4
|
2.079
|
|
OAS2
|
2'-5'-oligoadenylate synthetase 2, 69/71kDa
|
2.077
|
|
MX2
|
MX dynamin-like GTPase 2
|
2.074
|
|
OASL
|
2'-5'-oligoadenylate synthetase-like
|
2.072
|
|
TNF
|
tumor necrosis factor
|
2.048
|
|
IFNAR2
|
interferon (alpha, beta and omega) receptor 2
|
2.046
|
|
IFIT3
|
interferon-induced protein with tetratricopeptide repeats 3
|
2.042
|
|
TLR2
|
toll-like receptor 2
|
2.028
|
|
CD8A
|
CD8a molecule
|
2.009
|
|
IFI44
|
interferon-induced protein 44
|
2.007
|
|
IRF5
|
interferon regulatory factor 5
|
2.007
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
2.003
|
|
IFIT1B
|
interferon-induced protein with tetratricopeptide repeats 1B
|
1.993
|
|
IFNA4
|
interferon, alpha 4
|
1.983
|
|
OAS3
|
2'-5'-oligoadenylate synthetase 3, 100kDa
|
1.98
|
|
CD4
|
CD4 molecule
|
1.975
|
|
DHX58
|
DEXH (Asp-Glu-X-His) box polypeptide 58
|
1.968
|
|
IFNA17
|
interferon, alpha 17
|
1.964
|
|
IFITM3
|
interferon induced transmembrane protein 3
|
1.961
|
|
IFITM1
|
interferon induced transmembrane protein 1
|
1.955
|
|
CLEC4C
|
C-type lectin domain family 4, member C
|
1.953
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
1.949
|
|
IL10
|
interleukin 10
|
1.939
|
|
IFNL1
|
interferon, lambda 1
|
1.936
|
|
IFI27
|
interferon, alpha-inducible protein 27
|
1.931
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
1.925
|
|
CGAS
|
cyclic GMP-AMP synthase
|
1.898
|
|
IFNA13
|
interferon, alpha 13
|
1.891
|
|
IFNA14
|
interferon, alpha 14
|
1.881
|
|
IFNA8
|
interferon, alpha 8
|
1.876
|
|
IFNA6
|
interferon, alpha 6
|
1.87
|
|
IFIT2
|
interferon-induced protein with tetratricopeptide repeats 2
|
1.868
|
|
BST2
|
bone marrow stromal cell antigen 2
|
1.868
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
1.86
|
|
IFNA16
|
interferon, alpha 16
|
1.857
|
|
IFNA21
|
interferon, alpha 21
|
1.856
|
|
IFNA5
|
interferon, alpha 5
|
1.851
|
|
IFNA10
|
interferon, alpha 10
|
1.851
|
|
USP18
|
ubiquitin specific peptidase 18
|
1.847
|
|
IFNA7
|
interferon, alpha 7
|
1.833
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
1.814
|
|
TIRAP
|
toll-interleukin 1 receptor (TIR) domain containing adaptor protein
|
1.813
|
|
IFI6
|
interferon, alpha-inducible protein 6
|
1.789
|
|
TICAM1
|
toll-like receptor adaptor molecule 1
|
1.786
|
|
TANK
|
TRAF family member-associated NFKB activator
|
1.777
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
1.775
|
|
TLR1
|
toll-like receptor 1
|
1.773
|
|
IFNL2
|
interferon, lambda 2
|
1.771
|
|
TLR5
|
toll-like receptor 5
|
1.769
|
|
TYK2
|
tyrosine kinase 2
|
1.767
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
1.762
|
|
JAK1
|
Janus kinase 1
|
1.761
|
|
CD86
|
CD86 molecule
|
1.761
|
|
IFI35
|
interferon-induced protein 35
|
1.751
|
|
UNC93B1
|
unc-93 homolog B1 (C. elegans)
|
1.744
|
|
CD80
|
CD80 molecule
|
1.738
|
|
IRAK2
|
interleukin-1 receptor-associated kinase 2
|
1.732
|
|
IL18
|
interleukin 18
|
1.73
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
1.729
|
|
IL1A
|
interleukin 1, alpha
|
1.709
|
|
TGFB1
|
transforming growth factor, beta 1
|
1.706
|
|
RNASEL
|
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)
|
1.689
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
1.688
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
1.681
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
1.674
|
|
IRF8
|
interferon regulatory factor 8
|
1.666
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
1.666
|
|
PHRF1
|
PHD and ring finger domains 1
|
1.664
|
|
IRF2
|
interferon regulatory factor 2
|
1.655
|
|
IL4
|
interleukin 4
|
1.652
|
|
IFNL3
|
interferon, lambda 3
|
1.651
|
|
IL3RA
|
interleukin 3 receptor, alpha (low affinity)
|
1.629
|
|
LILRA4
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4
|
1.623
|
|
TRIM25
|
tripartite motif containing 25
|
1.612
|
|
IFI44L
|
interferon-induced protein 44-like
|
1.612
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
1.597
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
1.588
|
|
IFI16
|
interferon, gamma-inducible protein 16
|
1.587
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
1.586
|
|
GBP1
|
guanylate binding protein 1, interferon-inducible
|
1.586
|
|
IL15
|
interleukin 15
|
1.581
|
|
ISG20
|
interferon stimulated exonuclease gene 20kDa
|
1.577
|
|
ZBP1
|
Z-DNA binding protein 1
|
1.574
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
1.573
|
|
IFIT5
|
interferon-induced protein with tetratricopeptide repeats 5
|
1.572
|
|
IL2
|
interleukin 2
|
1.569
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
1.566
|
|
ACE2
|
angiotensin I converting enzyme 2
|
1.565
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
1.561
|
|
IL1R1
|
interleukin 1 receptor, type I
|
1.554
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
1.548
|
|
CXCL11
|
chemokine (C-X-C motif) ligand 11
|
1.547
|
|
CD274
|
CD274 molecule
|
1.54
|
|
JUN
|
jun proto-oncogene
|
1.537
|
|
AIM2
|
absent in melanoma 2
|
1.536
|
|
EPSTI1
|
epithelial stromal interaction 1 (breast)
|
1.534
|
|
IFNK
|
interferon, kappa
|
1.523
|
|
IFNE
|
interferon, epsilon
|
1.515
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
1.514
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
1.513
|
|
BANK1
|
B-cell scaffold protein with ankyrin repeats 1
|
1.496
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
1.489
|
|
TAB2
|
TGF-beta activated kinase 1/MAP3K7 binding protein 2
|
1.487
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
1.486
|
|
ICAM1
|
intercellular adhesion molecule 1
|
1.484
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
1.484
|
|
LOC124905743
|
low affinity immunoglobulin gamma Fc region receptor III-B
|
1.484
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
1.473
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
1.469
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
1.468
|
|
DDX60
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 60
|
1.461
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
1.461
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
1.46
|
|
CLSTN1
|
calsyntenin 1
|
1.454
|
|
FOXP3
|
forkhead box P3
|
1.449
|
|
CD19
|
CD19 molecule
|
1.446
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
1.446
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
1.441
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
1.439
|
|
NMI
|
N-myc (and STAT) interactor
|
1.426
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
1.425
|
|
IFNGR1
|
interferon gamma receptor 1
|
1.425
|
|
TP53
|
tumor protein p53
|
1.416
|
|
IFNLR1
|
interferon, lambda receptor 1
|
1.416
|
|
CCL19
|
chemokine (C-C motif) ligand 19
|
1.415
|
|
TRAT1
|
T cell receptor associated transmembrane adaptor 1
|
1.406
|
|
TAB3
|
TGF-beta activated kinase 1/MAP3K7 binding protein 3
|
1.405
|
|
IL13
|
interleukin 13
|
1.402
|
|
IL33
|
interleukin 33
|
1.401
|
|
GPR183
|
G protein-coupled receptor 183
|
1.4
|
|
TLR10
|
toll-like receptor 10
|
1.397
|
|
GBP4
|
guanylate binding protein 4
|
1.396
|
|
NRP1
|
neuropilin 1
|
1.386
|
|
STAT4
|
signal transducer and activator of transcription 4
|
1.386
|
|
TMEM140
|
transmembrane protein 140
|
1.383
|
|
RIPK1
|
receptor (TNFRSF)-interacting serine-threonine kinase 1
|
1.382
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
1.375
|
|
IL7
|
interleukin 7
|
1.372
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
1.367
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
1.36
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
1.356
|
|
ZNF395
|
zinc finger protein 395
|
1.353
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
1.352
|
|
TAB1
|
TGF-beta activated kinase 1/MAP3K7 binding protein 1
|
1.352
|
|
PARP9
|
poly (ADP-ribose) polymerase family, member 9
|
1.351
|
|
CD83
|
CD83 molecule
|
1.348
|
|
GPR75-ASB3
|
GPR75-ASB3 readthrough
|
1.344
|
|
TLR6
|
toll-like receptor 6
|
1.343
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
1.341
|
|
JAK2
|
Janus kinase 2
|
1.337
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
1.336
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
1.336
|
|
TRIM22
|
tripartite motif containing 22
|
1.334
|
|
CCL8
|
chemokine (C-C motif) ligand 8
|
1.33
|
|
IL10RB
|
interleukin 10 receptor, beta
|
1.327
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
1.327
|
|
SP5
|
Sp5 transcription factor
|
1.326
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
1.323
|
|
CHAC2
|
ChaC, cation transport regulator homolog 2 (E. coli)
|
1.323
|
|
HMGB1
|
high mobility group box 1
|
1.322
|
|
IRF4
|
interferon regulatory factor 4
|
1.322
|
|
IFITM2
|
interferon induced transmembrane protein 2
|
1.318
|
|
TBX21
|
T-box 21
|
1.317
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
1.314
|
|
FLT3
|
fms-related tyrosine kinase 3
|
1.314
|
|
GBP2
|
guanylate binding protein 2, interferon-inducible
|
1.314
|
|
IL5
|
interleukin 5
|
1.309
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
1.304
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
1.301
|
|
MMP9
|
matrix metallopeptidase 9
|
1.3
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
1.299
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
1.298
|
|
CXXC1
|
CXXC finger protein 1
|
1.297
|
|
IFNGR2
|
interferon gamma receptor 2 (interferon gamma transducer 1)
|
1.296
|
|
CISH
|
cytokine inducible SH2-containing protein
|
1.291
|
|
STING1
|
stimulator of interferon response cGAMP interactor 1
|
1.288
|
|
CCL7
|
chemokine (C-C motif) ligand 7
|
1.286
|
|
IL3
|
interleukin 3
|
1.286
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
1.284
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
1.284
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
1.276
|
|
TREX1
|
three prime repair exonuclease 1
|
1.271
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
1.269
|
|
CD40LG
|
CD40 ligand
|
1.268
|
|
DDX41
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 41
|
1.268
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
1.268
|
|
TRIM5
|
tripartite motif containing 5
|
1.262
|
|
ZNF426
|
zinc finger protein 426
|
1.258
|
|
GBP5
|
guanylate binding protein 5
|
1.257
|
|
CXCL2
|
chemokine (C-X-C motif) ligand 2
|
1.252
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
1.244
|
|
PDCD1
|
programmed cell death 1
|
1.242
|
|
CMPK2
|
cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial
|
1.237
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
1.234
|
|
IDO2
|
indoleamine 2,3-dioxygenase 2
|
1.234
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
1.232
|
|
TRIM24
|
tripartite motif containing 24
|
1.228
|
|
GDNF
|
glial cell derived neurotrophic factor
|
1.227
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
1.221
|
|
TRIM28
|
tripartite motif containing 28
|
1.22
|
|
XAF1
|
XIAP associated factor 1
|
1.213
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
1.21
|
|
MS4A7
|
membrane-spanning 4-domains, subfamily A, member 7
|
1.208
|
|
SIGLEC1
|
sialic acid binding Ig-like lectin 1, sialoadhesin
|
1.202
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
1.202
|
|
GSDMD
|
gasdermin D
|
1.199
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
1.196
|
|
CXCL5
|
chemokine (C-X-C motif) ligand 5
|
1.194
|
|
TINAGL1
|
tubulointerstitial nephritis antigen-like 1
|
1.194
|
|
IL22
|
interleukin 22
|
1.187
|
|
CCRL2
|
chemokine (C-C motif) receptor-like 2
|
1.183
|
|
NANOS2
|
nanos homolog 2 (Drosophila)
|
1.18
|
|
ADAR
|
adenosine deaminase, RNA-specific
|
1.179
|
|
FLT3LG
|
fms-related tyrosine kinase 3 ligand
|
1.178
|
|
SPIB
|
Spi-B transcription factor (Spi-1/PU.1 related)
|
1.175
|
|
LY96
|
lymphocyte antigen 96
|
1.173
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
1.172
|
|
CD1C
|
CD1c molecule
|
1.172
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
1.17
|
|
TRAF1
|
TNF receptor-associated factor 1
|
1.169
|
|
CD163
|
CD163 molecule
|
1.168
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
1.166
|
|
PIK3C3
|
phosphatidylinositol 3-kinase, catalytic subunit type 3
|
1.165
|
|
SAMHD1
|
SAM domain and HD domain 1
|
1.162
|
|
SYK
|
spleen tyrosine kinase
|
1.161
|
|
DPP9
|
dipeptidyl-peptidase 9
|
1.161
|
|
CLEC4A
|
C-type lectin domain family 4, member A
|
1.16
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
1.16
|
|
CD28
|
CD28 molecule
|
1.159
|
|
CLEC7A
|
C-type lectin domain family 7, member A
|
1.159
|
|
C1QB
|
complement component 1, q subcomponent, B chain
|
1.159
|
|
TRIM21
|
tripartite motif containing 21
|
1.156
|
|
CD276
|
CD276 molecule
|
1.156
|
|
ATF3
|
activating transcription factor 3
|
1.155
|
|
EGR1
|
early growth response 1
|
1.153
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
1.153
|
|
UBE2I
|
ubiquitin-conjugating enzyme E2I
|
1.152
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
1.149
|
|
TYROBP
|
TYRO protein tyrosine kinase binding protein
|
1.147
|
|
GBP6
|
guanylate binding protein family, member 6
|
1.146
|
|
PELI3
|
pellino E3 ubiquitin protein ligase family member 3
|
1.138
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
1.136
|
|
JAK3
|
Janus kinase 3
|
1.134
|
|
CD44
|
CD44 molecule (Indian blood group)
|
1.133
|
|
FN1
|
fibronectin 1
|
1.128
|
|
CCR6
|
chemokine (C-C motif) receptor 6
|
1.126
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
1.123
|
|
CD68
|
CD68 molecule
|
1.121
|
|
IL1R2
|
interleukin 1 receptor, type II
|
1.121
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
1.119
|
|
TRADD
|
TNFRSF1A-associated via death domain
|
1.119
|
|
PLSCR1
|
phospholipid scramblase 1
|
1.117
|
|
TREM2
|
triggering receptor expressed on myeloid cells 2
|
1.113
|
|
GBP7
|
guanylate binding protein 7
|
1.112
|
|
HERC5
|
HECT and RLD domain containing E3 ubiquitin protein ligase 5
|
1.109
|
|
EGFR
|
epidermal growth factor receptor
|
1.109
|
|
B2M
|
beta-2-microglobulin
|
1.108
|
|
CREB1
|
cAMP responsive element binding protein 1
|
1.107
|
|
IL27RA
|
interleukin 27 receptor, alpha
|
1.107
|
|
SH2D3A
|
SH2 domain containing 3A
|
1.104
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
1.104
|
|
THBS1
|
thrombospondin 1
|
1.104
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
1.102
|
|
CCR1
|
chemokine (C-C motif) receptor 1
|
1.099
|
|
CREBBP
|
CREB binding protein
|
1.098
|
|
HLA-DRA
|
major histocompatibility complex, class II, DR alpha
|
1.097
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
1.094
|
|
CXCL16
|
chemokine (C-X-C motif) ligand 16
|
1.093
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
1.092
|
|
CD3E
|
CD3e molecule, epsilon (CD3-TCR complex)
|
1.091
|
|
CD69
|
CD69 molecule
|
1.09
|
|
TRAF5
|
TNF receptor-associated factor 5
|
1.087
|
|
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64)
|
1.087
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
1.086
|
|
NLRP1
|
NLR family, pyrin domain containing 1
|
1.085
|
|
FAM167A
|
family with sequence similarity 167, member A
|
1.084
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
1.081
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
1.08
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
1.079
|
|
C1QA
|
complement component 1, q subcomponent, A chain
|
1.078
|
|
TAX1BP1
|
Tax1 (human T-cell leukemia virus type I) binding protein 1
|
1.077
|
|
ZFP62
|
ZFP62 zinc finger protein
|
1.075
|
|
LCN2
|
lipocalin 2
|
1.074
|
|
HELZ2
|
helicase with zinc finger 2, transcriptional coactivator
|
1.073
|
|
PTEN
|
phosphatase and tensin homolog
|
1.072
|
|
CD38
|
CD38 molecule
|
1.07
|
|
C3
|
complement component 3
|
1.069
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
1.067
|
|
IL17RA
|
interleukin 17 receptor A
|
1.065
|
|
AGXT
|
alanine-glyoxylate aminotransferase
|
1.064
|
|
NOD1
|
nucleotide-binding oligomerization domain containing 1
|
1.064
|
|
RHOXF1
|
Rhox homeobox family, member 1
|
1.055
|
|
TNIP1
|
TNFAIP3 interacting protein 1
|
1.051
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
1.049
|
|
IRAK3
|
interleukin-1 receptor-associated kinase 3
|
1.049
|
|
CCL22
|
chemokine (C-C motif) ligand 22
|
1.046
|
|
LILRB4
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4
|
1.046
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
1.045
|
|
CTSS
|
cathepsin S
|
1.042
|
|
UBE2N
|
ubiquitin-conjugating enzyme E2N
|
1.04
|
|
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9
|
1.039
|
|
NR1H2
|
nuclear receptor subfamily 1, group H, member 2
|
1.036
|
|
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B
|
1.033
|
|
NCAM1
|
neural cell adhesion molecule 1
|
1.027
|
|
CHAMP1
|
chromosome alignment maintaining phosphoprotein 1
|
1.027
|
|
CD27
|
CD27 molecule
|
1.026
|
|
INS
|
insulin
|
1.026
|
|
FSD1L
|
fibronectin type III and SPRY domain containing 1-like
|
1.025
|
|
HERC6
|
HECT and RLD domain containing E3 ubiquitin protein ligase family member 6
|
1.023
|
|
HSPB3
|
heat shock 27kDa protein 3
|
1.021
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
1.018
|
|
CXCL3
|
chemokine (C-X-C motif) ligand 3
|
1.018
|
|
CDPF1
|
cysteine-rich, DPF motif domain containing 1
|
1.014
|
|
PYCARD
|
PYD and CARD domain containing
|
1.014
|
|
APOE
|
apolipoprotein E
|
1.014
|
|
SEC14L1
|
SEC14-like 1 (S. cerevisiae)
|
1.013
|
|
IFNW1
|
interferon, omega 1
|
1.012
|
|
EGF
|
epidermal growth factor
|
1.01
|
|
GZMA
|
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)
|
1.008
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
1.006
|
|
PXDN
|
peroxidasin
|
1.004
|
|
AXL
|
AXL receptor tyrosine kinase
|
1.003
|
|
CSRP1
|
cysteine and glycine-rich protein 1
|
1.003
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
1.002
|
|
FBF1
|
Fas (TNFRSF6) binding factor 1
|
1.0
|
|
PXDNL
|
peroxidasin-like
|
0.999
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
0.995
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
0.994
|
|
TOLLIP
|
toll interacting protein
|
0.994
|
|
CCND1
|
cyclin D1
|
0.994
|
|
SELL
|
selectin L
|
0.994
|
|
NLRC4
|
NLR family, CARD domain containing 4
|
0.993
|
|
MSR1
|
macrophage scavenger receptor 1
|
0.992
|
|
EIF4EBP2
|
eukaryotic translation initiation factor 4E binding protein 2
|
0.992
|
|
PDCD1LG2
|
programmed cell death 1 ligand 2
|
0.991
|
|
BLNK
|
B-cell linker
|
0.991
|
|
NEURL1B
|
neuralized E3 ubiquitin protein ligase 1B
|
0.99
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
0.988
|
|
MRC1
|
mannose receptor, C type 1
|
0.988
|
|
HPRT1
|
hypoxanthine phosphoribosyltransferase 1
|
0.988
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
0.987
|
|
NEURL3
|
neuralized E3 ubiquitin protein ligase 3
|
0.986
|
|
SMAD3
|
SMAD family member 3
|
0.985
|
|
TIMD4
|
T-cell immunoglobulin and mucin domain containing 4
|
0.983
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
0.978
|
|
PXK
|
PX domain containing serine/threonine kinase
|
0.978
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
0.976
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
0.976
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
0.976
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
0.975
|
|
FOXO3
|
forkhead box O3
|
0.975
|
|
ZCCHC3
|
zinc finger, CCHC domain containing 3
|
0.974
|
|
NR1D2
|
nuclear receptor subfamily 1, group D, member 2
|
0.972
|
|
ZMYND11
|
zinc finger, MYND-type containing 11
|
0.972
|
|
DHX36
|
DEAH (Asp-Glu-Ala-His) box polypeptide 36
|
0.971
|
|
C1QC
|
complement component 1, q subcomponent, C chain
|
0.971
|
|
DOCK2
|
dedicator of cytokinesis 2
|
0.969
|
|
CD209
|
CD209 molecule
|
0.962
|
|
IL11
|
interleukin 11
|
0.96
|
|
ACOD1
|
aconitate decarboxylase 1
|
0.958
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
0.957
|
|
TNNC1
|
troponin C type 1 (slow)
|
0.956
|
|
TMEM156
|
transmembrane protein 156
|
0.955
|
|
PARP12
|
poly (ADP-ribose) polymerase family, member 12
|
0.954
|
|
SCARB2
|
scavenger receptor class B, member 2
|
0.954
|
|
PCNA
|
proliferating cell nuclear antigen
|
0.949
|
|
FOXP4
|
forkhead box P4
|
0.949
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
0.949
|
|
NLRX1
|
NLR family member X1
|
0.948
|
|
CDHR3
|
cadherin-related family member 3
|
0.947
|
|
NFKBIZ
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta
|
0.946
|
|
IRGM
|
immunity-related GTPase family, M
|
0.945
|
|
FASN
|
fatty acid synthase
|
0.945
|
|
FKBP5
|
FK506 binding protein 5
|
0.945
|
|
DAXX
|
death-domain associated protein
|
0.944
|
|
SETDB1
|
SET domain, bifurcated 1
|
0.944
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
0.943
|
|
LILRA5
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5
|
0.943
|
|
IL9
|
interleukin 9
|
0.943
|
|
PF4
|
platelet factor 4
|
0.942
|
|
SETDB2
|
SET domain, bifurcated 2
|
0.942
|
|
PEX11B
|
peroxisomal biogenesis factor 11 beta
|
0.941
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
0.941
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
0.941
|
|
IL6R
|
interleukin 6 receptor
|
0.939
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
0.938
|
|
IL7R
|
interleukin 7 receptor
|
0.937
|
|
USP25
|
ubiquitin specific peptidase 25
|
0.936
|
|
SOCS6
|
suppressor of cytokine signaling 6
|
0.935
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
0.933
|
|
EMILIN2
|
elastin microfibril interfacer 2
|
0.932
|
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
0.93
|
|
BAX
|
BCL2-associated X protein
|
0.93
|
|
TMED7-TICAM2
|
TMED7-TICAM2 readthrough
|
0.93
|
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1
|
0.929
|
|
ATG5
|
autophagy related 5
|
0.929
|
|
MPPE1
|
metallophosphoesterase 1
|
0.928
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
0.928
|
|
GUSB
|
glucuronidase, beta
|
0.928
|
|
LAMP1
|
lysosomal-associated membrane protein 1
|
0.927
|
|
TRIM17
|
tripartite motif containing 17
|
0.927
|
|
ESR1
|
estrogen receptor 1
|
0.925
|
|
ACKR2
|
atypical chemokine receptor 2
|
0.923
|
|
IL12B
|
interleukin 12B
|
0.922
|
|
TRIM69
|
tripartite motif containing 69
|
0.921
|
|
LOC102723407
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8
|
0.92
|
|
C1S
|
complement component 1, s subcomponent
|
0.917
|
|
CLEC4E
|
C-type lectin domain family 4, member E
|
0.916
|
|
IL4R
|
interleukin 4 receptor
|
0.914
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
0.914
|
|
RCHY1
|
ring finger and CHY zinc finger domain containing 1, E3 ubiquitin protein ligase
|
0.913
|
|
STEAP1B
|
STEAP family member 1B
|
0.912
|
|
DAND5
|
DAN domain family member 5, BMP antagonist
|
0.911
|
|
TRAFD1
|
TRAF-type zinc finger domain containing 1
|
0.91
|
|
LGALS9
|
lectin, galactoside-binding, soluble, 9
|
0.909
|
|
LZTFL1
|
leucine zipper transcription factor-like 1
|
0.908
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
0.908
|
|
RNF31
|
ring finger protein 31
|
0.907
|
|
ERVW-1
|
endogenous retrovirus group W, member 1
|
0.907
|
|
AHR
|
aryl hydrocarbon receptor
|
0.906
|
|
SDHC
|
succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa
|
0.906
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
0.905
|
|
COL1A1
|
collagen, type I, alpha 1
|
0.905
|
|
ITGAE
|
integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)
|
0.903
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
0.902
|
|
TRIM15
|
tripartite motif containing 15
|
0.902
|
|
MT1A
|
metallothionein 1A
|
0.9
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
0.898
|
|
PNMA5
|
paraneoplastic Ma antigen family member 5
|
0.897
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
0.896
|
|
DHX33
|
DEAH (Asp-Glu-Ala-His) box polypeptide 33
|
0.896
|
|
BCL2L1
|
BCL2-like 1
|
0.895
|
|
ICAM3
|
intercellular adhesion molecule 3
|
0.895
|
|
C3AR1
|
complement component 3a receptor 1
|
0.895
|
|
CXCR6
|
chemokine (C-X-C motif) receptor 6
|
0.893
|
|
CCN2
|
cellular communication network factor 2
|
0.893
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
0.891
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
0.891
|
|
LRRC20
|
leucine rich repeat containing 20
|
0.89
|
|
THBD
|
thrombomodulin
|
0.889
|
|
RTP4
|
receptor (chemosensory) transporter protein 4
|
0.889
|
|
FCER1A
|
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide
|
0.888
|
|
SH2D3C
|
SH2 domain containing 3C
|
0.888
|
|
SPI1
|
Spi-1 proto-oncogene
|
0.887
|
|
PLP2
|
proteolipid protein 2 (colonic epithelium-enriched)
|
0.886
|
|
XBP1
|
X-box binding protein 1
|
0.884
|
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8
|
0.884
|
|
MCEMP1
|
mast cell-expressed membrane protein 1
|
0.884
|
|
CST7
|
cystatin F (leukocystatin)
|
0.883
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
0.882
|
|
CSTF2
|
cleavage stimulation factor, 3' pre-RNA, subunit 2, 64kDa
|
0.882
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
0.882
|
|
DHX9
|
DEAH (Asp-Glu-Ala-His) box helicase 9
|
0.881
|
|
DPRX
|
divergent-paired related homeobox
|
0.88
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
0.88
|
|
MMP13
|
matrix metallopeptidase 13
|
0.88
|
|
BCL3
|
B-cell CLL/lymphoma 3
|
0.879
|
|
ADA
|
adenosine deaminase
|
0.879
|
|
EP300
|
E1A binding protein p300
|
0.877
|
|
CD33
|
CD33 molecule
|
0.876
|
|
S100A8
|
S100 calcium binding protein A8
|
0.876
|
|
NFKBIB
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta
|
0.875
|
|
HDAC9
|
histone deacetylase 9
|
0.875
|
|
HAMP
|
hepcidin antimicrobial peptide
|
0.874
|
|
ASZ1
|
ankyrin repeat, SAM and basic leucine zipper domain containing 1
|
0.873
|
|
LAG3
|
lymphocyte-activation gene 3
|
0.871
|
|
NCR2
|
natural cytotoxicity triggering receptor 2
|
0.87
|
|
HMOX1
|
heme oxygenase 1
|
0.869
|
|
GATA3
|
GATA binding protein 3
|
0.869
|
|
PSMB8
|
proteasome (prosome, macropain) subunit, beta type, 8
|
0.867
|
|
SOCS2
|
suppressor of cytokine signaling 2
|
0.867
|
|
LRRC56
|
leucine rich repeat containing 56
|
0.866
|
|
NLRC5
|
NLR family, CARD domain containing 5
|
0.865
|
|
GOLGA6C
|
golgin A6 family, member C
|
0.864
|
|
CEBPD
|
CCAAT/enhancer binding protein (C/EBP), delta
|
0.863
|
|
GUCY1B1
|
guanylate cyclase 1 soluble subunit beta 1
|
0.862
|
|
CPXM1
|
carboxypeptidase X (M14 family), member 1
|
0.861
|
|
DTX3L
|
deltex 3 like, E3 ubiquitin ligase
|
0.86
|
|
SCARB1
|
scavenger receptor class B, member 1
|
0.859
|
|
IL13RA1
|
interleukin 13 receptor, alpha 1
|
0.858
|
|
SLPI
|
secretory leukocyte peptidase inhibitor
|
0.858
|
|
CARD19
|
caspase recruitment domain family member 19
|
0.858
|
|
HLA-DQB2
|
major histocompatibility complex, class II, DQ beta 2
|
0.857
|
|
GMNN
|
geminin, DNA replication inhibitor
|
0.857
|
|
SELPLG
|
selectin P ligand
|
0.855
|
|
COL20A1
|
collagen, type XX, alpha 1
|
0.855
|
|
C4A
|
complement component 4A (Rodgers blood group)
|
0.853
|
|
AGTR1
|
angiotensin II receptor, type 1
|
0.852
|
|
XKR6
|
XK, Kell blood group complex subunit-related family, member 6
|
0.851
|
|
IL17RB
|
interleukin 17 receptor B
|
0.849
|
|
CD300LF
|
CD300 molecule-like family member f
|
0.849
|
|
ENTPD1
|
ectonucleoside triphosphate diphosphohydrolase 1
|
0.847
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
0.847
|
|
ZNF277
|
zinc finger protein 277
|
0.846
|
|
NR1D1
|
nuclear receptor subfamily 1, group D, member 1
|
0.845
|
|
CD34
|
CD34 molecule
|
0.845
|
|
PML
|
promyelocytic leukemia
|
0.845
|
|
ATL1
|
atlastin GTPase 1
|
0.844
|
|
IRF2BP2
|
interferon regulatory factor 2 binding protein 2
|
0.843
|
|
APOD
|
apolipoprotein D
|
0.842
|
|
FGF13
|
fibroblast growth factor 13
|
0.842
|
|
RNASE9
|
ribonuclease, RNase A family, 9 (non-active)
|
0.842
|
|
C1R
|
complement component 1, r subcomponent
|
0.842
|
|
UBE2V1
|
ubiquitin-conjugating enzyme E2 variant 1
|
0.841
|
|
HSP90AB1
|
heat shock protein 90kDa alpha (cytosolic), class B member 1
|
0.841
|
|
CASP10
|
caspase 10, apoptosis-related cysteine peptidase
|
0.841
|
|
TIGIT
|
T cell immunoreceptor with Ig and ITIM domains
|
0.839
|
|
RBCK1
|
RanBP-type and C3HC4-type zinc finger containing 1
|
0.838
|
|
FCER1G
|
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide
|
0.837
|
|
MYO1F
|
myosin IF
|
0.836
|
|
CXCL14
|
chemokine (C-X-C motif) ligand 14
|
0.835
|
|
PELI2
|
pellino E3 ubiquitin protein ligase family member 2
|
0.835
|
|
TRIM35
|
tripartite motif containing 35
|
0.834
|
|
TSLP
|
thymic stromal lymphopoietin
|
0.832
|
|
CCL24
|
chemokine (C-C motif) ligand 24
|
0.832
|
|
MICB
|
MHC class I polypeptide-related sequence B
|
0.831
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
0.831
|
|
PRKCD
|
protein kinase C, delta
|
0.83
|
|
OPTN
|
optineurin
|
0.829
|
|
ARL2BP
|
ADP-ribosylation factor-like 2 binding protein
|
0.826
|
|
PPP1CA
|
protein phosphatase 1, catalytic subunit, alpha isozyme
|
0.826
|
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4
|
0.825
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
0.825
|
|
MAPK11
|
mitogen-activated protein kinase 11
|
0.824
|
|
CTSB
|
cathepsin B
|
0.823
|
|
DDX3X
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked
|
0.823
|
|
CCL23
|
chemokine (C-C motif) ligand 23
|
0.822
|
|
NR2F6
|
nuclear receptor subfamily 2, group F, member 6
|
0.821
|
|
GPNMB
|
glycoprotein (transmembrane) nmb
|
0.818
|
|
MMP2
|
matrix metallopeptidase 2
|
0.816
|
|
TCF7L1
|
transcription factor 7-like 1 (T-cell specific, HMG-box)
|
0.816
|
|
ELANE
|
elastase, neutrophil expressed
|
0.815
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
0.812
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
0.812
|
|
CCR3
|
chemokine (C-C motif) receptor 3
|
0.811
|
|
DEFB1
|
defensin, beta 1
|
0.809
|
|
CYTIP
|
cytohesin 1 interacting protein
|
0.808
|
|
IL10RA
|
interleukin 10 receptor, alpha
|
0.807
|
|
CYSTM1
|
cysteine-rich transmembrane module containing 1
|
0.806
|
|
NOTO
|
notochord homeobox
|
0.805
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
0.805
|
|
RUNX1
|
runt-related transcription factor 1
|
0.805
|
|
NFXL1
|
nuclear transcription factor, X-box binding-like 1
|
0.804
|
|
CD22
|
CD22 molecule
|
0.803
|
|
IL15RA
|
interleukin 15 receptor, alpha
|
0.803
|
|
TNFRSF18
|
tumor necrosis factor receptor superfamily, member 18
|
0.803
|
|
ARID5A
|
AT rich interactive domain 5A (MRF1-like)
|
0.802
|
|
BCL7A
|
B-cell CLL/lymphoma 7A
|
0.802
|
|
MINDY3
|
MINDY lysine 48 deubiquitinase 3
|
0.802
|
|
MEFV
|
Mediterranean fever
|
0.801
|
|
HDAC1
|
histone deacetylase 1
|
0.8
|
|
CASP6
|
caspase 6, apoptosis-related cysteine peptidase
|
0.8
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
0.799
|
|
CFB
|
complement factor B
|
0.798
|
|
INKA2
|
inka box actin regulator 2
|
0.797
|
|
COL1A2
|
collagen, type I, alpha 2
|
0.796
|
|
MLKL
|
mixed lineage kinase domain-like
|
0.796
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
0.796
|
|
ICOS
|
inducible T-cell co-stimulator
|
0.796
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
0.796
|
|
ATM
|
ATM serine/threonine kinase
|
0.796
|
|
LIF
|
leukemia inhibitory factor
|
0.794
|
|
TGFB2
|
transforming growth factor, beta 2
|
0.791
|
|
DCBLD1
|
discoidin, CUB and LCCL domain containing 1
|
0.791
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
0.791
|
|
USP7
|
ubiquitin specific peptidase 7 (herpes virus-associated)
|
0.791
|
|
LY6D
|
lymphocyte antigen 6 complex, locus D
|
0.789
|
|
ARG2
|
arginase 2
|
0.787
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
0.786
|
|
CARD9
|
caspase recruitment domain family, member 9
|
0.786
|
|
SQSTM1
|
sequestosome 1
|
0.786
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
0.785
|
|
ERFE
|
erythroferrone
|
0.785
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
0.784
|
|
RNF122
|
ring finger protein 122
|
0.783
|
|
XCR1
|
chemokine (C motif) receptor 1
|
0.783
|
|
S100A12
|
S100 calcium binding protein A12
|
0.781
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
0.78
|
|
ULK1
|
unc-51 like autophagy activating kinase 1
|
0.777
|
|
TNFRSF4
|
tumor necrosis factor receptor superfamily, member 4
|
0.777
|
|
RNASEH2C
|
ribonuclease H2, subunit C
|
0.776
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
0.775
|
|
MOV10
|
Mov10 RISC complex RNA helicase
|
0.775
|
|
FKBP7
|
FK506 binding protein 7
|
0.775
|
|
LGALS9C
|
lectin, galactoside-binding, soluble, 9C
|
0.772
|
|
PIAS2
|
protein inhibitor of activated STAT, 2
|
0.772
|
|
ETV7
|
ets variant 7
|
0.772
|
|
LOC102723996
|
ICOS ligand
|
0.772
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
0.769
|
|
DUXA
|
double homeobox A
|
0.769
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
0.769
|
|
GCA
|
grancalcin, EF-hand calcium binding protein
|
0.769
|
|
KAT2A
|
K(lysine) acetyltransferase 2A
|
0.768
|
|
CASP5
|
caspase 5, apoptosis-related cysteine peptidase
|
0.768
|
|
CD47
|
CD47 molecule
|
0.768
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
0.768
|
|
PELI1
|
pellino E3 ubiquitin protein ligase 1
|
0.768
|
|
OTULIN
|
OTU deubiquitinase with linear linkage specificity
|
0.767
|
|
FOXP1
|
forkhead box P1
|
0.765
|
|
POSTN
|
periostin, osteoblast specific factor
|
0.765
|
|
IER3
|
immediate early response 3
|
0.765
|
|
CH25H
|
cholesterol 25-hydroxylase
|
0.764
|
|
PLPPR3
|
phospholipid phosphatase related 3
|
0.764
|
|
C4B
|
complement component 4B (Chido blood group)
|
0.763
|
|
TRIM23
|
tripartite motif containing 23
|
0.763
|
|
SLC6A20
|
solute carrier family 6 (proline IMINO transporter), member 20
|
0.762
|
|
SERPINA3
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3
|
0.762
|
|
MUC1
|
mucin 1, cell surface associated
|
0.762
|
|
IL1RL1
|
interleukin 1 receptor-like 1
|
0.761
|
|
S100A9
|
S100 calcium binding protein A9
|
0.76
|
|
COL3A1
|
collagen, type III, alpha 1
|
0.76
|
|
NCR1
|
natural cytotoxicity triggering receptor 1
|
0.759
|
|
RIPK3
|
receptor-interacting serine-threonine kinase 3
|
0.758
|
|
TRIM29
|
tripartite motif containing 29
|
0.758
|
|
BTN3A3
|
butyrophilin, subfamily 3, member A3
|
0.758
|
|
MEDAG
|
mesenteric estrogen-dependent adipogenesis
|
0.758
|
|
AIF1
|
allograft inflammatory factor 1
|
0.757
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
0.756
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
0.755
|
|
RNF11
|
ring finger protein 11
|
0.754
|
|
PIAS1
|
protein inhibitor of activated STAT, 1
|
0.753
|
|
VAMP3
|
vesicle-associated membrane protein 3
|
0.753
|
|
CCR9
|
chemokine (C-C motif) receptor 9
|
0.753
|
|
SOCS5
|
suppressor of cytokine signaling 5
|
0.753
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
0.752
|
|
H1-4
|
H1.4 linker histone, cluster member
|
0.752
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
0.751
|
|
FPR2
|
formyl peptide receptor 2
|
0.751
|
|
NKX2-3
|
NK2 homeobox 3
|
0.751
|
|
ULBP1
|
UL16 binding protein 1
|
0.751
|
|
DTX3
|
deltex 3, E3 ubiquitin ligase
|
0.751
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
0.75
|
|
LAMP5
|
lysosomal-associated membrane protein family, member 5
|
0.747
|
|
PTX3
|
pentraxin 3, long
|
0.746
|
|
IL21R
|
interleukin 21 receptor
|
0.745
|
|
RNF135
|
ring finger protein 135
|
0.745
|
|
PIKFYVE
|
phosphoinositide kinase, FYVE finger containing
|
0.745
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
0.744
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
0.744
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
0.744
|
|
AREG
|
amphiregulin
|
0.743
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
0.743
|
|
SELE
|
selectin E
|
0.743
|
|
ZBTB18
|
zinc finger and BTB domain containing 18
|
0.742
|
|
SIRPA
|
signal-regulatory protein alpha
|
0.741
|
|
AOC3
|
amine oxidase, copper containing 3
|
0.741
|
|
AURKAIP1
|
aurora kinase A interacting protein 1
|
0.74
|
|
NAIP
|
NLR family, apoptosis inhibitory protein
|
0.74
|
|
AFF3
|
AF4/FMR2 family, member 3
|
0.739
|
|
USP17L25
|
ubiquitin specific peptidase 17-like family member 25
|
0.738
|
|
FAM114A2
|
family with sequence similarity 114, member A2
|
0.738
|
|
BLK
|
BLK proto-oncogene, Src family tyrosine kinase
|
0.738
|
|
CR1L
|
complement component (3b/4b) receptor 1-like
|
0.737
|
|
FHDC1
|
FH2 domain containing 1
|
0.737
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
0.737
|
|
EIF2AK4
|
eukaryotic translation initiation factor 2 alpha kinase 4
|
0.737
|
|
ZC3HAV1
|
zinc finger CCCH-type, antiviral 1
|
0.737
|
|
PTMA
|
prothymosin, alpha
|
0.736
|
|
DUSP2
|
dual specificity phosphatase 2
|
0.736
|
|
LTF
|
lactotransferrin
|
0.735
|
|
MT2A
|
metallothionein 2A
|
0.734
|
|
CSF2RA
|
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage)
|
0.733
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
0.733
|
|
MMUT
|
methylmalonyl-CoA mutase
|
0.733
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
0.732
|
|
BECN1
|
beclin 1, autophagy related
|
0.732
|
|
ABCF1
|
ATP-binding cassette, sub-family F (GCN20), member 1
|
0.732
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
0.732
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
0.73
|
|
ZBTB3
|
zinc finger and BTB domain containing 3
|
0.729
|
|
PRSS23
|
protease, serine, 23
|
0.729
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
0.729
|
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C
|
0.729
|
|
CALCOCO2
|
calcium binding and coiled-coil domain 2
|
0.728
|
|
CDK1
|
cyclin-dependent kinase 1
|
0.727
|
|
DLC1
|
DLC1 Rho GTPase activating protein
|
0.727
|
|
PIM3
|
Pim-3 proto-oncogene, serine/threonine kinase
|
0.727
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
0.726
|
|
LITAF
|
lipopolysaccharide-induced TNF factor
|
0.726
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
0.725
|
|
GFI1
|
growth factor independent 1 transcription repressor
|
0.725
|
|
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog
|
0.725
|
|
SLFN13
|
schlafen family member 13
|
0.724
|
|
TAPBP
|
TAP binding protein (tapasin)
|
0.723
|
|
SIRT1
|
sirtuin 1
|
0.722
|
|
ICAM4
|
intercellular adhesion molecule 4 (Landsteiner-Wiener blood group)
|
0.72
|
|
NEK7
|
NIMA-related kinase 7
|
0.719
|
|
ANXA5
|
annexin A5
|
0.719
|
|
PIK3AP1
|
phosphoinositide-3-kinase adaptor protein 1
|
0.719
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
0.718
|
|
IFI27L2
|
interferon, alpha-inducible protein 27-like 2
|
0.718
|
|
TGFB3
|
transforming growth factor, beta 3
|
0.717
|
|
ICOSLG
|
inducible T-cell co-stimulator ligand
|
0.717
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
0.717
|
|
OTUD7B
|
OTU deubiquitinase 7B
|
0.716
|
|
NDUFA2
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2, 8kDa
|
0.716
|
|
MOG
|
myelin oligodendrocyte glycoprotein
|
0.714
|
|
SULT1C3
|
sulfotransferase family, cytosolic, 1C, member 3
|
0.714
|
|
RNASEH2B
|
ribonuclease H2, subunit B
|
0.713
|
|
TRIM59
|
tripartite motif containing 59
|
0.713
|
|
BRCA1
|
breast cancer 1, early onset
|
0.712
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
0.71
|
|
MRE11
|
MRE11 homolog, double strand break repair nuclease
|
0.71
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
0.709
|
|
PLD4
|
phospholipase D family, member 4
|
0.709
|
|
CD1D
|
CD1d molecule
|
0.708
|
|
ATG7
|
autophagy related 7
|
0.708
|
|
PARP14
|
poly (ADP-ribose) polymerase family, member 14
|
0.705
|
|
TRIM56
|
tripartite motif containing 56
|
0.704
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
0.704
|
|
CHEK1
|
checkpoint kinase 1
|
0.704
|
|
OCA2
|
oculocutaneous albinism II
|
0.702
|
|
CD2AP
|
CD2-associated protein
|
0.702
|
|
POTEF
|
POTE ankyrin domain family, member F
|
0.7
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
0.7
|
|
TSPAN4
|
tetraspanin 4
|
0.7
|
|
TBP
|
TATA box binding protein
|
0.699
|
|
BCL11B
|
B-cell CLL/lymphoma 11B (zinc finger protein)
|
0.699
|
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
0.698
|
|
LY75-CD302
|
LY75-CD302 readthrough
|
0.698
|
|
PKP3
|
plakophilin 3
|
0.698
|
|
ECSIT
|
ECSIT signalling integrator
|
0.697
|
|
FOSL2
|
FOS-like antigen 2
|
0.696
|
|
CYCS
|
cytochrome c, somatic
|
0.696
|
|
CRKL
|
v-crk avian sarcoma virus CT10 oncogene homolog-like
|
0.695
|
|
CD247
|
CD247 molecule
|
0.694
|
|
RPP14
|
ribonuclease P/MRP 14kDa subunit
|
0.694
|
|
CD226
|
CD226 molecule
|
0.694
|
|
LAPTM5
|
lysosomal protein transmembrane 5
|
0.694
|
|
CXXC5
|
CXXC finger protein 5
|
0.693
|
|
RSL24D1
|
ribosomal L24 domain containing 1
|
0.693
|
|
VCAN
|
versican
|
0.693
|
|
ZNF417
|
zinc finger protein 417
|
0.691
|
|
IL17F
|
interleukin 17F
|
0.691
|
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9
|
0.691
|
|
HLA-DQA2
|
major histocompatibility complex, class II, DQ alpha 2
|
0.69
|
|
MPO
|
myeloperoxidase
|
0.689
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
0.689
|
|
ZNF432
|
zinc finger protein 432
|
0.689
|
|
F13A1
|
coagulation factor XIII, A1 polypeptide
|
0.688
|
|
CD2
|
CD2 molecule
|
0.688
|
|
ZNF652
|
zinc finger protein 652
|
0.687
|
|
GALNTL5
|
polypeptide N-acetylgalactosaminyltransferase-like 5
|
0.686
|
|
CITED2
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
|
0.686
|
|
CARD11
|
caspase recruitment domain family, member 11
|
0.686
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
0.686
|
|
SFRP5
|
secreted frizzled-related protein 5
|
0.685
|
|
LGMN
|
legumain
|
0.683
|
|
CCL13
|
chemokine (C-C motif) ligand 13
|
0.683
|
|
DICER1
|
dicer 1, ribonuclease type III
|
0.683
|
|
SULT1B1
|
sulfotransferase family, cytosolic, 1B, member 1
|
0.683
|
|
H3C7
|
H3 clustered histone 7
|
0.683
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
0.682
|
|
TBKBP1
|
TBK1 binding protein 1
|
0.681
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
0.681
|
|
DUSP5
|
dual specificity phosphatase 5
|
0.681
|
|
DUSP4
|
dual specificity phosphatase 4
|
0.681
|
|
UBB
|
ubiquitin B
|
0.68
|
|
SULT1C4
|
sulfotransferase family, cytosolic, 1C, member 4
|
0.68
|
|
IFRD2
|
interferon-related developmental regulator 2
|
0.68
|
|
BCR
|
breakpoint cluster region
|
0.679
|
|
JAG1
|
jagged 1
|
0.679
|
|
MT1H
|
metallothionein 1H
|
0.678
|
|
BBC3
|
BCL2 binding component 3
|
0.677
|
|
PIDD1
|
p53-induced death domain protein 1
|
0.676
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
0.676
|
|
SPRR1A
|
small proline-rich protein 1A
|
0.676
|
|
MCL1
|
myeloid cell leukemia 1
|
0.675
|
|
DNASE1
|
deoxyribonuclease I
|
0.675
|
|
LTA
|
lymphotoxin alpha
|
0.675
|
|
SAMSN1
|
SAM domain, SH3 domain and nuclear localization signals 1
|
0.674
|
|
UBC
|
ubiquitin C
|
0.674
|
|
FOSL1
|
FOS-like antigen 1
|
0.674
|
|
RHEB
|
Ras homolog enriched in brain
|
0.673
|
|
FZR1
|
fizzy/cell division cycle 20 related 1 (Drosophila)
|
0.673
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
0.671
|
|
RORA
|
RAR-related orphan receptor A
|
0.67
|
|
FGF7
|
fibroblast growth factor 7
|
0.67
|
|
NOTCH1
|
notch 1
|
0.669
|
|
ZBTB46
|
zinc finger and BTB domain containing 46
|
0.669
|
|
IFI30
|
interferon, gamma-inducible protein 30
|
0.668
|
|
TSC22D1
|
TSC22 domain family, member 1
|
0.666
|
|
LOX
|
lysyl oxidase
|
0.666
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
0.666
|
|
H3-3B
|
H3.3 histone B
|
0.664
|
|
NLRC3
|
NLR family, CARD domain containing 3
|
0.663
|
|
NLRP6
|
NLR family, pyrin domain containing 6
|
0.663
|
|
ANK1
|
ankyrin 1, erythrocytic
|
0.663
|
|
ACE
|
angiotensin I converting enzyme
|
0.662
|
|
CCM2
|
cerebral cavernous malformation 2
|
0.661
|
|
SUMO2
|
small ubiquitin-like modifier 2
|
0.661
|
|
DTX4
|
deltex 4, E3 ubiquitin ligase
|
0.661
|
|
CSF2RB
|
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)
|
0.66
|
|
BIRC2
|
baculoviral IAP repeat containing 2
|
0.659
|
|
ATG13
|
autophagy related 13
|
0.659
|
|
PPIA
|
peptidylprolyl isomerase A (cyclophilin A)
|
0.658
|
|
CD53
|
CD53 molecule
|
0.658
|
|
NR2F1
|
nuclear receptor subfamily 2, group F, member 1
|
0.658
|
|
H3-4
|
H3.4 histone, cluster member
|
0.658
|
|
TREM1
|
triggering receptor expressed on myeloid cells 1
|
0.657
|
|
PPT1
|
palmitoyl-protein thioesterase 1
|
0.656
|
|
DIAPH1
|
diaphanous-related formin 1
|
0.656
|
|
KCTD11
|
potassium channel tetramerization domain containing 11
|
0.655
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
0.654
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
0.654
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
0.653
|
|
PGM5
|
phosphoglucomutase 5
|
0.652
|
|
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5
|
0.652
|
|
IL17RC
|
interleukin 17 receptor C
|
0.652
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
0.651
|
|
BDNF
|
brain-derived neurotrophic factor
|
0.651
|
|
FOXO1
|
forkhead box O1
|
0.65
|
|
SLC11A1
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1
|
0.649
|
|
RPP38
|
ribonuclease P/MRP 38kDa subunit
|
0.649
|
|
ULBP2
|
UL16 binding protein 2
|
0.649
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
0.647
|
|
HBP1
|
HMG-box transcription factor 1
|
0.647
|
|
DDX53
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 53
|
0.647
|
|
MEOX2
|
mesenchyme homeobox 2
|
0.647
|
|
CD72
|
CD72 molecule
|
0.647
|
|
CDK6
|
cyclin-dependent kinase 6
|
0.646
|
|
BORCS8
|
BLOC-1 related complex subunit 8
|
0.646
|
|
LYG2
|
lysozyme G-like 2
|
0.645
|
|
BRD4
|
bromodomain containing 4
|
0.645
|
|
KLRC2
|
killer cell lectin-like receptor subfamily C, member 2
|
0.645
|
|
H3-7
|
H3.7 histone (putative)
|
0.645
|
|
MLLT3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3
|
0.644
|
|
H3-5
|
H3.5 histone
|
0.644
|
|
H3C13
|
H3 clustered histone 13
|
0.644
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
0.642
|
|
TXNIP
|
thioredoxin interacting protein
|
0.642
|
|
TGIF1
|
TGFB-induced factor homeobox 1
|
0.642
|
|
CXXC4
|
CXXC finger protein 4
|
0.64
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
0.64
|
|
PGR
|
progesterone receptor
|
0.639
|
|
MKNK1
|
MAP kinase interacting serine/threonine kinase 1
|
0.639
|
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa
|
0.639
|
|
GYPC
|
glycophorin C (Gerbich blood group)
|
0.639
|
|
APP
|
amyloid beta (A4) precursor protein
|
0.638
|
|
C5AR1
|
complement component 5a receptor 1
|
0.638
|
|
NECTIN2
|
nectin cell adhesion molecule 2
|
0.637
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
0.636
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
0.636
|
|
TAF6L
|
TAF6-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor, 65kDa
|
0.636
|
|
RICTOR
|
RPTOR independent companion of MTOR, complex 2
|
0.634
|
|
TMC6
|
transmembrane channel-like 6
|
0.634
|
|
GFAP
|
glial fibrillary acidic protein
|
0.632
|
|
GSDME
|
gasdermin E
|
0.632
|
|
MALT1
|
MALT1 paracaspase
|
0.631
|
|
LDLR
|
low density lipoprotein receptor
|
0.63
|
|
MAPK13
|
mitogen-activated protein kinase 13
|
0.63
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
0.629
|
|
HMGCS1
|
3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble)
|
0.629
|
|
SMAD2
|
SMAD family member 2
|
0.629
|
|
RAPH1
|
Ras association (RalGDS/AF-6) and pleckstrin homology domains 1
|
0.629
|
|
SREBF2
|
sterol regulatory element binding transcription factor 2
|
0.629
|
|
CCL1
|
chemokine (C-C motif) ligand 1
|
0.629
|
|
NKG7
|
natural killer cell granule protein 7
|
0.628
|
|
TNFSF14
|
tumor necrosis factor (ligand) superfamily, member 14
|
0.628
|
|
ATG12
|
autophagy related 12
|
0.627
|
|
CDK4
|
cyclin-dependent kinase 4
|
0.627
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
0.626
|
|
ZUP1
|
zinc finger containing ubiquitin peptidase 1
|
0.626
|
|
CALHM6
|
calcium homeostasis modulator family member 6
|
0.626
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
0.625
|
|
FURIN
|
furin (paired basic amino acid cleaving enzyme)
|
0.624
|
|
SERINC2
|
serine incorporator 2
|
0.623
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
0.623
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
0.623
|
|
RB1CC1
|
RB1-inducible coiled-coil 1
|
0.623
|
|
TMEM119
|
transmembrane protein 119
|
0.622
|
|
TRIM38
|
tripartite motif containing 38
|
0.622
|
|
RASGRP3
|
RAS guanyl releasing protein 3 (calcium and DAG-regulated)
|
0.621
|
|
KLRC1
|
killer cell lectin-like receptor subfamily C, member 1
|
0.618
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
0.616
|
|
SUV39H1
|
suppressor of variegation 3-9 homolog 1 (Drosophila)
|
0.614
|
|
MPEG1
|
macrophage expressed 1
|
0.614
|
|
KL
|
klotho
|
0.614
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
0.613
|
|
CFH
|
complement factor H
|
0.612
|
|
PLAC8
|
placenta-specific 8
|
0.612
|
|
DROSHA
|
drosha, ribonuclease type III
|
0.612
|
|
MATN4
|
matrilin 4
|
0.612
|
|
SSUH2
|
ssu-2 homolog (C. elegans)
|
0.612
|
|
ITGB6
|
integrin, beta 6
|
0.611
|
|
WDR73
|
WD repeat domain 73
|
0.611
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
0.611
|
|
C5
|
complement component 5
|
0.611
|
|
SOCS4
|
suppressor of cytokine signaling 4
|
0.611
|
|
GOT2
|
glutamic-oxaloacetic transaminase 2, mitochondrial
|
0.611
|
|
NKX2-8
|
NK2 homeobox 8
|
0.61
|
|
DUSP16
|
dual specificity phosphatase 16
|
0.61
|
|
ELF5
|
E74-like factor 5 (ets domain transcription factor)
|
0.609
|
|
REST
|
RE1-silencing transcription factor
|
0.608
|
|
HDAC3
|
histone deacetylase 3
|
0.608
|
|
CNOT6
|
CCR4-NOT transcription complex, subunit 6
|
0.608
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
0.606
|
|
RHOV
|
ras homolog family member V
|
0.605
|
|
RBPJ
|
recombination signal binding protein for immunoglobulin kappa J region
|
0.605
|
|
SSBP3
|
single stranded DNA binding protein 3
|
0.605
|
|
EIF4G2
|
eukaryotic translation initiation factor 4 gamma, 2
|
0.604
|
|
ATF4
|
activating transcription factor 4
|
0.604
|
|
MAP3K6
|
mitogen-activated protein kinase kinase kinase 6
|
0.604
|
|
HSD17B4
|
hydroxysteroid (17-beta) dehydrogenase 4
|
0.603
|
|
CXCR5
|
chemokine (C-X-C motif) receptor 5
|
0.603
|
|
IL20RA
|
interleukin 20 receptor, alpha
|
0.602
|
|
COL8A1
|
collagen, type VIII, alpha 1
|
0.602
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
0.602
|
|
LY6E
|
lymphocyte antigen 6 complex, locus E
|
0.602
|
|
MMP8
|
matrix metallopeptidase 8
|
0.6
|
|
OVOL1
|
ovo-like zinc finger 1
|
0.6
|
|
MAP2K3
|
mitogen-activated protein kinase kinase 3
|
0.599
|
|
ANKRD66
|
ankyrin repeat domain 66
|
0.598
|
|
THPO
|
thrombopoietin
|
0.598
|
|
HDAC2
|
histone deacetylase 2
|
0.597
|
|
CCL18
|
chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated)
|
0.596
|
|
HCK
|
HCK proto-oncogene, Src family tyrosine kinase
|
0.596
|
|
ERV3-1
|
endogenous retrovirus group 3, member 1
|
0.596
|
|
EIF4A3
|
eukaryotic translation initiation factor 4A3
|
0.596
|
|
SLCO4A1
|
solute carrier organic anion transporter family, member 4A1
|
0.596
|
|
USP15
|
ubiquitin specific peptidase 15
|
0.595
|
|
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B
|
0.595
|
|
TCF7
|
transcription factor 7 (T-cell specific, HMG-box)
|
0.595
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
0.595
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
0.595
|
|
SLC41A3
|
solute carrier family 41, member 3
|
0.595
|
|
VWF
|
von Willebrand factor
|
0.594
|
|
SMAD4
|
SMAD family member 4
|
0.594
|
|
MCM8
|
minichromosome maintenance complex component 8
|
0.593
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
0.593
|
|
ZBTB16
|
zinc finger and BTB domain containing 16
|
0.593
|
|
EIF4B
|
eukaryotic translation initiation factor 4B
|
0.593
|
|
PTPN2
|
protein tyrosine phosphatase, non-receptor type 2
|
0.592
|
|
BRINP1
|
bone morphogenetic protein/retinoic acid inducible neural-specific 1
|
0.592
|
|
DOCK8
|
dedicator of cytokinesis 8
|
0.591
|
|
IGSF6
|
immunoglobulin superfamily, member 6
|
0.591
|
|
AICDA
|
activation-induced cytidine deaminase
|
0.591
|
|
KDM4D
|
lysine (K)-specific demethylase 4D
|
0.591
|
|
ANGPT1
|
angiopoietin 1
|
0.591
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
0.59
|
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1
|
0.589
|
|
TERT
|
telomerase reverse transcriptase
|
0.589
|
|
CD1B
|
CD1b molecule
|
0.589
|
|
TRIM6-TRIM34
|
TRIM6-TRIM34 readthrough
|
0.588
|
|
CLEC4M
|
C-type lectin domain family 4, member M
|
0.588
|
|
IL20RB
|
interleukin 20 receptor beta
|
0.588
|
|
IL2RB
|
interleukin 2 receptor, beta
|
0.588
|
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha
|
0.588
|
|
EPAS1
|
endothelial PAS domain protein 1
|
0.587
|
|
ITIH4
|
inter-alpha-trypsin inhibitor heavy chain family, member 4
|
0.586
|
|
OGN
|
osteoglycin
|
0.586
|
|
ADAMTS15
|
ADAM metallopeptidase with thrombospondin type 1 motif, 15
|
0.586
|
|
CD70
|
CD70 molecule
|
0.586
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
0.585
|
|
UVRAG
|
UV radiation resistance associated
|
0.583
|
|
USP17L2
|
ubiquitin specific peptidase 17-like family member 2
|
0.582
|
|
PAX5
|
paired box 5
|
0.582
|
|
SOS1
|
son of sevenless homolog 1 (Drosophila)
|
0.581
|
|
PABPC1
|
poly(A) binding protein, cytoplasmic 1
|
0.581
|
|
LPL
|
lipoprotein lipase
|
0.58
|
|
IL6ST
|
interleukin 6 signal transducer
|
0.58
|
|
ULBP3
|
UL16 binding protein 3
|
0.58
|
|
RNASEH2A
|
ribonuclease H2, subunit A
|
0.579
|
|
RAG1
|
recombination activating gene 1
|
0.579
|
|
HSPB2
|
heat shock 27kDa protein 2
|
0.578
|
|
PEPD
|
peptidase D
|
0.578
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
0.577
|
